Sandra Hoogerwerf, MD
Encore Borland Groover Clinical Research (EBGCR)Biography
Dr. Sandra Hoogerwerf is board certified in gastroenterology and internal medicine. Dr. Sandra Hoogerwerf has a deep understanding of digestive health issues, and functional bowel and motility disorders.
Dr. Sandra Hoogerwerf graduated cum laude with a Doctorate of Medicine from the Erasmus University in Rotterdam, The Netherlands. She subsequently completed her internal medicine residency at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, and her clinical gastroenterology fellowship at the University of Texas Medical Branch in Galveston, Texas. In addition, she completed a gastroenterological research fellowship at Johns Hopkins University in Baltimore, Maryland.
Notes
Dr. Sandra Hoogerwerf graduated cum laude with a Doctorate of Medicine from the Erasmus University in Rotterdam, The Netherlands. She subsequently completed her internal medicine residency at Johns Hopkins Bayview Medical Center in Baltimore, Maryland and her clinical gastroenterology fellowship at the University of Texas Medical Branch in Galveston, Texas. In addition, she completed a gastroenterological research fellowship at the Johns Hopkins University in Baltimore, Maryland. Before joining Borland Groover in 2010, she served as an assistant professor of medicine at the University of Michigan Medical Center in Ann Arbor, Michigan.
Dr. Hoogerwerf has a longstanding interest in women’s health issues, functional bowel and motility disorders. She has published on a variety of topics including the management of gastrointestinal disease in pregnancy, acid suppressive therapy and reflux disease, irritable bowel syndrome and motility disorders such as achalasia.
CERTIFICATIONS
Internal Medicine, 1997
Gastroenterology, 2001
Our Clinical Research Principal Investigators strive to improve patient outcomes through cutting-edge clinical research. Our team of world-renowned specialists is committed to transforming medicine by conducting groundbreaking clinical trials. Our Clinical Research Principal Investigators are leaders in pharmacologic outcome clinical trials, particularly with new agents in Phases I-III. Our esteemed physicians can provide patients with early access to pioneering medications and devices by conducting clinical trials. With extensive clinical research expertise, our team advances medical knowledge daily and addresses serious health issues to enhance people’s lives today and tomorrow.